Evidence map›Paper›PMID 31810074›Full record

ArticleBiomedical materials (Bristol, England)2020

Fast dissolving glucose porogens for early calcium phosphate cement degradation and bone regeneration.

Eline-Claire Grosfeld, Brandon T Smith, Marco Santoro, Irene Lodoso-Torrecilla, John A Jansen, Dietmar Jo Ulrich, Anthony J Melchiorri, David W Scott, Antonios G Mikos, Jeroen J J P van den Beucken

Abstract read
In one paragraph

Article in Biomedical materials (Bristol, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eline-Claire GrosfeldRadboudumc, Dentistry-Biomaterials, Philips van Leijdenlaan 25, 6525EX Nijmegen, The Netherlands.
Brandon T SmithRice University, Bioengineering, Houston TX, United States of America.
Marco SantoroRice University, Bioengineering, Houston TX, United States of America.
Irene Lodoso-TorrecillaRadboudumc, Dentistry-Biomaterials, Philips van Leijdenlaan 25, 6525EX Nijmegen, The Netherlands.
John A JansenRadboudumc, Dentistry-Biomaterials, Philips van Leijdenlaan 25, 6525EX Nijmegen, The Netherlands.
Dietmar Jo UlrichRadboudumc, Plastic and Reconstructive Surgery, Nijmegen, The Netherlands.
Anthony J MelchiorriNIH/NIBIB Center for Engineering Complex Tissues, Houston TX, United States of America.
David W ScottRice University, Statistics, Houston TX, United States of America.
Antonios G MikosRice University, Bioengineering, Houston TX, United States of America.ORCID 0000-0002-0709-990X
Jeroen J J P van den BeuckenRadboudumc, Dentistry-Biomaterials, Philips van Leijdenlaan 25, 6525EX Nijmegen, The Netherlands.ORCID 0000-0002-0301-1966

Funding

Rapidly-Degrading Calcium Phosphate Cements for Orthopedic Tissue Engineering.F30AR071258 · NIAMS · RICE UNIVERSITY · PI SMITH, BRANDON · 2017 to 2020
$168k
NIAMS NIH HHS F30 AR071258
6 · The paper itself

Abstract

Here, we demonstrate the in vivo efficacy of glucose microparticles (GMPs) to serve as porogens within calcium phosphate cements (CPCs) to obtain a fast-degrading bone substitute material. Composites were fabricated incorporating 20 wt% GMPs at two different GMP size ranges (100-150 μm (GMP-S) and 150-300 μm (GMP-L)), while CPC containing 20 wt% poly(lactic-co-glycolic acid) microparticles (PLGA) and plain CPC served as controls. After 2 and 8 weeks implantation in a rat femoral condyle defect model, specimens were retrieved and analyzed for material degradation and bone formation. Histologically, no adverse tissue response to any of the CPC-formulations was observed. All CPC-porogen formulations showed faster degradation compared to plain CPC control, but only GMP-containing formulations showed higher amounts of new bone formation compared to plain CPC controls. After 8 weeks, only CPC-porogen formulations with GMP-S or PLGA porogens showed higher degradation compared to plain CPC controls. Overall, the inclusion of GMPs into CPCs resulted in a macroporous structure that initially accelerated the generation of new bone. These findings highlight the efficacy of a novel approach that leverages simple porogen properties to generate porous CPCs with distinct degradation and bone regeneration profiles.

Indexed as

AnimalsBone CementsBone RegenerationBone SubstitutesCalcium PhosphatesFemurGlucoseMaleMicrospheresOsteogenesisPolylactic Acid-Polyglycolic Acid CopolymerPorosityRatsRats, WistarX-Ray MicrotomographyBone CementsBone Substitutescalcium phosphateCalcium PhosphatesGlucosePolylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID31810074
PMCPMC7683932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.